Evidence map›Paper›PMID 30987723›Full record

ArticleJournal of food and drug analysis2019

Detection of BPDE-DNA adducts in human umbilical cord blood by LC-MS/MS analysis.

Ling Guo, Xiao Jiang, Hao-Yuan Tian, Shang-Jin Yao, Bo-Ya Li, Rong-Jie Zhang, Shu-Sheng Zhang, Xin Sun

Open access · hybridAbstract read
In one paragraph

Article in Journal of food and drug analysis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Detection of Benzo[Toxics · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ling GuoKey Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100050 Beijing, China.
Xiao JiangKey Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100050 Beijing, China.
Hao-Yuan TianKey Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100050 Beijing, China.
Shang-Jin YaoKey Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100050 Beijing, China.
Bo-Ya LiKey Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100050 Beijing, China.
Rong-Jie ZhangHenan Center for Disease Control and Prevention, Zhengzhou 450016, China.
Shu-Sheng ZhangDepartment of Chemistry, Zhengzhou University, Zhengzhou 450001, China.
Xin SunKey Laboratory of Chemical Safety and Health, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 100050 Beijing, China.
National Institute for Occupational Health and Poison Control · CNHenan Provincial Center for Disease Control and Prevention · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Benzo [a]pyrene (BaP) is a model compound for the study of polycyclic aromatic hydrocarbon (PAH) carcinogenesis. Upon metabolism, BaP is metabolized to the ultimate metabolite, BaP trans-7,8-diol-anti-9,10-epoxide (BPDE), that reacts with cellular DNA to form BPDE-dG adducts responsible for BaP-induced mutagenicity, carcinogenicity, and teratogenicity. In this study, we employed our developed LC-MS/MS method to detect and quantity BPDE-dG adducts present in 42 normal human umbilical cord blood samples and 42 birth defect cases. We determined that there is no significant difference in the level of BPDE-dG formation between the normal and birth defect groups. This represents the first time to use an LC-MS/MS method to quantify BPDE-dG in human umbilical blood samples. The results indicated that under experimental conditions, BPDE-dG adducts were detected in all the human umbilical cord blood samples from the normal and birth defect groups.

Indexed as

7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideChromatography, LiquidDNA AdductsFemaleFetal BloodHumansMolecular ConformationPregnancyTandem Mass Spectrometry7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidebenzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNADNA AdductsBPDE-dGHuman biomonitoringLC-MS/MSMolecular epidemiology

Identifiers

PMID30987723
PMCPMC9296209
OpenAlexW2928336652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.